Publication Details

AFRICAN RESEARCH NEXUS

SHINING A SPOTLIGHT ON AFRICAN RESEARCH

medicine

Novel Treatment of Infant with COVID-19 with the Sialidase Fusion Protein, DAS181

Pediatric Infectious Disease Journal, Volume 40, No. 6, Year 2021

We describe the successful treatment of a 10-month-old female with respiratory distress secondary to Coronavirus disease 2019 (COVID-19) with the nebulized investigational drug, DAS181. Therapy was well tolerated, and the patient had minimal side effects. The patient's respiratory distress and positive viral polymerase chain reaction rapidly resolved after initiation of therapy. © 2021 Lippincott Williams and Wilkins. All rights reserved.
Statistics
Citations: 1
Authors: 7
Affiliations: 2
Research Areas
Covid
Health System And Policy
Maternal And Child Health
Participants Gender
Female